Experimental Endotoxemia Drug Performs Poorly in Horse Study
Pirfenidone, a unique experimental drug with anti-fibrotic and anti-inflammatory properties, afforded no apparent therapeutic benefit in horses with experimentally-induced endotoxemia, leaving Cal Davis researchers rather disappointed.
“Previous studies led us to believe that pirfenidone would minimize the effects o